Patent US4657849A successfully refreshed from Google Patents.
US4657849A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compositions and methods useful for uropathogenic bacterial identification or diagnosis and inhibition of adherence of uropathogenic bacteria to cells having a structural element similar to that of the active principle of the invention
Assignee: Svenska Sockerfabriks AB
•
Filing: 1981-03-05
•
Granted: 1987-04-14
•
Expires: 2001-03-05
Abstract
Abstract Compositions and methods useful for identification or diagnostic use, or inhibition of adherence of uropathogenic bacteria to cells, all in connection with uropathogenic bacterial infections, containing as an active constituent the structural element, preferably in terminal position: α--D--Galp--(1-4)--D--Gal. process for identification or quantification of such structural element in native biological material from mammals including man, comprising using antibodies, the generation of which has been initiated by such composition. A process for the identification of bacterial acceptor structures (pili, syn. fimbriae) recognizing the described structural element, comprising using this recognition. A process for purifying acceptor structures of bacteria, comprising using for the purification the affinity between such structural element and the corresponding acceptor structures on the bacteria. A method of diagnosing mammals including man in regard to a tendency toward bacterial infection involving such receptor structure, comprising generating antibodies against said receptor structure and recording the reaction of said antibodies and cells from the mammal.
Inventors
- 👤 Gunilla P. Kallenius
- 👤 Karl A. Lundblad
- 👤 Nils R. Mollby
- 👤 Stefan B. Svensson
- 👤 Jan Winberg
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 07:49
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54353; A; A61; A61K; A61K35/00; A61K35/12; A61K35/14; A61K35/18; C; C07; C07H; C07H3/00; C07H3/06; C07K; C07K14/00; C07K14/195; C07K14/24; C07K14/245; C07K16/00; C07K16/12; C07K16/1203; C07K16/1228; C07K16/1232; G01N33/544; G01N33/569; G01N33/56911; A61K38/00; A61K39/00
Claims Analysis
Total Claims: 22
Claim 1
Independent Claim
104 words
A composition useful for uropathogenic bacterial identification or diagnosis containing, as active principle, an oligosaccharide, compound comprising, in terminal position, a structural element consisting essentially of α--D--Gal--(1-4)--D--Gal (I), which structural element is recognized by the uropathogenic bacterial receptor system, wherein the oligosaccharide compound consists essentially of α--D--Gal--(1-4)--D--Gal--(S).sub.n --L--MMB (II), wherein (S) n represents one or more optional additional saccharide moieties, L represents a linking arm covalently attached to the adjacent saccharide moiety, and MMB represents a nontoxic and noninterfering macromolecular carrier covalently attached to said linking arm and selected from the group consisting of proteins, polypeptides, polysaccharides, aliphatic hydrocarbons, and natural and synthetic polymers.
Claim 2
Dependent Claim
104 words
A composition useful for uropathogenic bacterial identification or diagnosis containing, as active principle, an oligosaccharide, compound comprising, in terminal position, a structural element consisting essentially of α--D--Gal--(1-4)--D--Gal (I), which structural element is recognized by the uropathogenic bacterial receptor system, wherein the oligosaccharide compound consists essentially of α--D--Gal--(1-4)--D--Gal--(S).sub.n --L--MMB (II), wherein (S) n represents one or more optional additional saccharide moieties, L represents a linking arm covalently attached to the adjacent saccharide moiety, and MMB represents a nontoxic and noninterfering macromolecular carrier covalently attached to said linking arm and selected from the group consisting of proteins, polypeptides, polysaccharides, aliphatic hydrocarbons, and natural and synthetic polymers.
Claim 3
Dependent Claim
108 words
A composition useful for uropathogenic bacterial identification or diagnosis containing, as active principle, an oligosaccharide compound comprising, in terminal position, a structural element consisting essentially of α--D--Galp--(1-4)--α-- or β--D--Galp (Ia), which structural element is recognized by the uropathogenic bacterial receptor system, wherein the oligosaccharide compound consists essentially of α--D--Galp--(1-4)--α or β--D--Galp--(S.sub.n --L--MMB (IIa), wherein (S) n represents one or more optional additional saccharide moieties, L represents a linking arm covalently attached to the adjacent saccharide moiety, and MMB represents a nontoxic and noninterfering macromolecular carrier covalently attached to said linking arm and selected from the group consisting of proteins, polypeptides, polysaccharides, aliphatic hydrocarbons, and natural and synthetic polymers.
Claim 4
Dependent Claim
108 words
A composition useful for uropathogenic bacterial identification or diagnosis containing, as active principle, an oligosaccharide compound comprising, in terminal position, a structural element consisting essentially of α--D--Galp--(1-4)--α-- or β--D--Galp (Ia), which structural element is recognized by the uropathogenic bacterial receptor system, wherein the oligosaccharide compound consists essentially of α--D--Galp--(1-4)--α or β--D--Galp--(S.sub.n --L--MMB (IIa), wherein (S) n represents one or more optional additional saccharide moieties, L represents a linking arm covalently attached to the adjacent saccharide moiety, and MMB represents a nontoxic and noninterfering macromolecular carrier covalently attached to said linking arm and selected from the group consisting of proteins, polypeptides, polysaccharides, aliphatic hydrocarbons, and natural and synthetic polymers.
Claim 5
Dependent Claim
16 words
A composition according to claim 2, wherein in that said structural element has the formula: α--D--Galp--(1-4)--β--D--Galp.
Claim 6
Dependent Claim
16 words
A composition according to claim 2, wherein in that said structural element has the formula: α--D--Galp--(1-4)--α--D--Galp.
Claim 7
Dependent Claim
38 words
A composition according to claim 2, wherein in that said structural element plus (S) n has the formula: α--D--Galp--(1-4)--α or β--D--Galp--1--O--R, wherein R is a nontoxic and noninterfering organic residue which is attached in either α or β-configuration.
Claim 8
Dependent Claim
18 words
A composition according to claim 2, in that said structural element plus (S) n has the formula: α--D--Galp--(1-4)--β--D--Galp--(1-4)--D--Glc.
Claim 9
Dependent Claim
19 words
A composition according to claim 6, wherein in that said structural element plus (S) n has the formula: α--D--Galp--(1-4)--β--D--Galp--(1-4)--β--D--Glc.
Claim 10
Dependent Claim
19 words
A composition according to claim 6, wherein in that said structural element plus (S) n has the formula: α--D--Galp--(1-4)--β--D--Galp--(1-4)--α--D--Glc.
Claim 11
Dependent Claim
38 words
A composition according to claim 6, wherein in that said structural element plus (S) n has the formula: α--D--Galp--(1-4)--β--D--Galp--(1-4)--α or β--D--Glcp--1--O--R, wherein R is an nontoxic and noninterfering organic residue which is attached in either α or β-configuration.
Claim 12
Dependent Claim
17 words
A composition according to claim 2, containing as in the structural element plus (S) n : α--D--Galp--(1-4)--β--D--Galp--(1-4)--D--Glucitol.
Claim 13
Dependent Claim
18 words
A composition according to claim 9, containing in the structural element plus (S) n : α--D--Galp--(1-4)--β--D--Galp--(1-4)--α--D--Glcp--1--O--Me or α--D--Galp--(1-4)--β--D--Galp--(1-4)--β--D--Glcp--1--O--Me.
Claim 14
Dependent Claim
16 words
A composition according to claim 2, containing in the structural element plus (S) n : α--D--Galp--(1-4)--β--D--Galp--(1-4)--β--D--GlcNAcp--(1-3)--β--D--Galp--(1-4)--D--Glc.
Claim 15
Dependent Claim
110 words
A composition according to claim 2, characterized in that the linking arm between the structural element and the macromolecular carrier is comprised in a structure which consists of: omega structural element ##STR12## macromolecular carrier, omega structural element ##STR13## macromolecular carrier, omega structural element ##STR14## macromolecular carrier, omega structural element ##STR15## macromolecular carrier, omega structural element aldonic acid ##STR16## macromolecular carrier, or omega structural element --NH(CH 2 ) n --CO--NH-- macromolecular carrier, wherein n can vary between 1 and 20, said structural element being bonded to the linking arm by a terminal reducing sugar residue which, in the case of the aldonic acid ##STR17## group is in its aldonic acid form.
Claim 16
Dependent Claim
16 words
A composition according to claim 2, containing as the structural element plus (S) n : α--D--Galp--(1-4)--β--D--Galp--(1-4)--β--D--Glcp--1--O--Ceramide.
Claim 17
Dependent Claim
16 words
A composition according to claim 2, containing as the structural element plus (S) n : α--D--Galp--(1-4)--β--D--Galp--(1-4)--β--D--GlcNAcp--(1-3)--β--D--Galp--(1-4)--β--D--Glcp--1--O--Ceramide.
Claim 18
Dependent Claim
17 words
A composition according to claim 2, containing as in the structural element plus (S) n : α--D--Galp--(1-4)--β--D--Galp--1--O--Ceramide.
Claim 19
Dependent Claim
45 words
A composition of claim 2, wherein (S) n is selected from one or more of alpha and beta D-glucose, alpha and beta D glucitol, alpha and beta D-glucopyranosyl, alpha and beta 2-acetamido-2-deoxy-glucopyranosyl, and alpha and beta D-galactopyranosyl, and a further alpha and beta D-glucose moiety.
Claim 20
Dependent Claim
66 words
A process for identification or quantification of the structural element of formula Ia in native biological material from mammals including man, characterized by the step of using antibodies, the generation of which has been initiated by a composition according to claim 2, and the further step of identifying or quantifying the said structural element in the biological material based upon the observable characteristics of said antibodies.
Claim 21
Dependent Claim
73 words
A method of diagnosing a mammal including man with respect to a tendency toward uropathogenic bacterial infection, comprising the step of generating antibodies against the receptor structure of formula Ia by the employment of a composition of claim 2, the further step of contacting said antibodies with mammalian cells from the mammal being diagnosed, and the further step of observing the extent of interaction between said antibodies and said cells from said mammal.
Claim 22
Dependent Claim
53 words
A process for identifying uropathogenic bacteria possessing a receptor structure which recognizes the structural element of formula Ia, comprising the step of contacting said bacteria with a composition of claim 2 and the further step of observing the extent of recognition of said structural element by said bacteria based upon observable physical phenomenon.
References Cited (Backward Citations)
US4137401A
Cited
US4238473A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-04-13 | 1990-10-13 | 1991-04-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-04-13 | 1994-10-13 | 1995-04-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-04-13 | 1998-10-13 | 1999-04-14 | $7700.00 | Window Closed / Lapsed |